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Three medicinal plants, Erythrina excelsa, Phytolacca dodecandra and Cucumis aculeatus, collected 
from Siaya and Migori District in Kenya, were screen d for the presence of phytochemicals. These plants have 
diverse compounds including phenolics, terpenoids, anthraquinones, alkaloids and flavonoids, whereby the 
terpenoids were the most abundant. The antimicrobial activity of the hexane, dichloromethane, ethyl acet te, 
methanol and water extracts from the stem barks, root barks and the leaves of selected medicinal plants were 
assayed against eight microorganisms. In comparison with the standard antibiotics (chloramphenicol), the 
dichloromethane extract presented a high activity against Pseudomonas aeruginosa ATCC 27853 and a 
moderate activity on Salmonella typhi (Clinical isolate). The methanol extract presented significant activity 
against clinical fungal isolates, Microsporum gypseum and Trychophyton mentagrophytes.  The hexane and 
ethyl acetate extract of Cucumis aculeatus leaves were active against P. aeruginosa ATCC 27853, whereas the 
dichloromethane extract of Erythrina excelsa had antibacterial activity against S aphylococcus aureus ATCC 
25923. Hexane, dichloromethane and water extracts of Erythrina excelsa also showed activity against 
Pseudomonas aeruginosa ATCC 27853. These investigations shows that various extracts obtained from 
Erythrina excelsa, Phytolacca dodecandra and Cucumis aculeatus could be used in vitro to inhibit the growth 
of some important bacteria and fungi. The above results justify the reason why these medicinal plants have 
been and are being used to treat the fungal and bacterial infections by the Luo community. 
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Plants have proved to be significant 
natural resources for medicines; 
documentation of their use in medicine 
originates from ancient times. Ethnobotanical 
plants provide a rich resource for natural drug 
research and development (Nkunya, 2002; 
Kong et al., 2008).  Medicinal plant-based 
drugs have the added advantage of being 
simple, effective and offering a broad 
spectrum of activity with greater emphasis on 
preventive action (Chin et al., 2006). 





Natural products and their derivatives 
represent more than 50% of all the drugs in 
clinical use in the world. Well-known 
examples of plant-derived medicines include 
quinine, morphine, codeine, aspirin, atropine, 
reserpine and cocaine. Important anti-cancer 
drugs such as taxol from Taxus baccata and 
vincristine from Catharanthus roseus have 
been developed (En-Erick et al., 2002). 
Therefore, with emerging and re-emerging 
infections and spread of deadly, drug-resistant 
strains of organisms, plant-based drugs could 
provide both concepts of therapy as well as 
therapeutic agents to complement modern 
medicine especially in antibiotics resistant 
microbial pathogens. Thus, the search for 
antimicrobial agents is of the utmost 
importance.  
In Kenya, the rural communities depend 
on plant resources mainly for herbal 
medicines (Kokwaro, 1993). Traditional 
healers claim that their medicine is cheaper 
and more effective than modern medicine. In 
developing countries, low-income people such 
as farmers, people of small isolated villages 
and native communities use folk medicine for 
the treatment of common infections. The 
plants Phytolacca dodecandra, Cucumis 
aculeatus and Erythrina excelsa are used in 
folk medicine in the treatment of several 
diseases.  
Phytolacca dodecandra leaves are used 
for treating ringworms, roots and stem used 
for dysentery and other stomach disorders and 
the seeds are used as molluscidal. Some 
studies done on this plant have shown 
significant molluscicidal properties, but in 
concentrations far too high for use in practical 
applications (Allen-Gil and Aldea, 2003). 
Cucumis aculeatus fruits are used for treating 
abscesses in children, leaves and stem are 
used for treating dysentery. The cucubitacins 
metabolites which are biologically active and 
highly cytotoxic have been isolated from this 
plant (Neuwinger, 1994). Erythrina excelsa 
bark is used for gastrointestinal disorders, 
amoebeasis and an anti-dote for snake-bites. 
However, up to date, little research has been 
done to investigate these traditionally used 
plants. Although numerous studies have been 
carried out on using natural products for 
screening antimicrobial activity (Matu and 
Van Staden 2003; Moshi et al., 2006), no 
attention has been given to Phytolacca 
dodecandra, Cucumis aculeatus and Erythrina 
excelsa antimicrobial activity. The main 
objective of these investigations was to 
establish the phytochemical profiles and relate 
the bioactivities to the ethnomedical use of 
these plants. 
We report on our findings of some 
antibacterial and antifungal effects of various 
organic and aqueous extracts from leaves of 
Phytolacca dodecandra, Cucumis aculeatus 
and Erythrina excelsa against a wide range of 
pathogenic bacteria and dermatophyte strains.  
 
MATERIALS AND METHODS 
Plant material 
The plant materials for Phytolacca 
dodecandra, Cucumis aculeatus and Erythrina 
excelsa were collected from Siaya District and 
Migori District in Nyanza Province in 
December 2007. These were taken to Biology 
Department at the Catholic University of 
Eastern Africa (CUEA) for identification. The 




The dried and powdered plant materials 
(100 g) were extracted using organic solvents 
and water. To obtain the organic extract, 
successive extraction was done using hexane, 
dichloromethane, ethyl acetate and methanol. 
The material was soaked at room temperature 
for 24 hours and then the extract filtered. The 
resultant extract was concentrated under 
reduced pressure at 40 oC using rotary 
evaporator. The water extract was then 
obtained by taking 50 g of plant material of 
each sample, weighed and soaked in distilled 





water. This was then put into a water bath at a 
temperature of 60 oC for about one and a half 
hours, then filtered using cotton wool and 
stored in a deep-freezer to avoid moulds 
growing in it. The extract was freeze dried for 
three days. All the dried extracts both organic 
and aqueous were weighed so as to calculate 
the percentage yield of the various samples. 
The dried materials were stored at –20 °C 
(McCloud et al., 1988).  
 
Phytochemical screening 
The hexane, dichloromethane, ethyl 
acetate, methanol and aqueous extracts of 
Phytolacca dodecandra, Cucumis aculeatus 
and Erythrina excelsa  were analyzed by 
qualitative method (thin layer chromatography 
on silica gel/UV detection at 365 nm) for 
presence of alkaloids, saponins, 
anthraquinones, flavonoids, phenol, and 
terpenoids (Orech et al., 2005; Edeoga et al., 
2005). For the extracts of hexane, 
dichloromethane and ethyl acetate, the solvent 
system used to run the TLC was a mixture of 
dichloromethane and hexane at a ratio of 9:1 
respectively. A different solvent system was 
used for the methanol extracts which was a 
mixture of dichloromethane and methanol in 
the ratio of 3:1 respectively. The plates were 
then visualized under Ultraviolet light at 364 
to 235 nm to determine those extracts with 
fluorescing compounds. The plates were then 
sprayed or exposed to different reagents to 
identify the compounds present.  
 
Bioassays 
Screening for antibacterial activity 
Antimicrobial activity was done at the 
Mycology Laboratories, Center for 
Microbiology Research - Kenya Medical 
Research Institute (KEMRI) following 
standard methods described in the Clinical 
Laboratory Standard Institute (CLSI). The 
procedure was done using disc diffusion 
method (Sing et al., 2002). The crude plant 
extracts were dissolved in DMSO and then 
vortexes to enhance their solubility in the 
DMSO. The prepared plates were then labeled 
and then discs (Whatman 6 mm), 10 µl of the 
extract impregnated in every disc. Aseptically 
the disc was transferred to plates inoculated 
with 0.5 Mac Farland standard of the test 
bacteria. The plates were then incubated 
overnight at a temperature of 35 oC. The 
diameter of inhibition zones for all the 
extracts were measured and recorded. The 
activities of the extracts were tested against 
Methicilline Resistant Staphylococcus aureus 
ATCC 25923 (MRSA), Salmonella typhi 
(Clinical isolate), Pseudomonas aeruginosa 
ATCC 27853 and Escherichia coli ATCC 
25922.  
 
Screening for antifungal activity 
This was done at Mycology laboratory, 
CMR, KEMRI, following standard methods. 
The procedures were done as described 
previously by disc diffusion method (Sing et 
al., 2002). The activity of the extracts were 
tested against Cryptococcus neoformans 
ATCC 66037, Candida albicans ATCC 
90028, Microsporum gypseum KMCC Mg 
201 and Trychophyton mentagrophytes 
KMCC TM 200. The crude plant extracts 
were dissolved in DMSO and then vortexed to 
enhance their solubility in the DMSO. The 
prepared plates were inoculated with 0.5 Mac 
Farland standard of the test fungi and disc 
impregnated with 10 µl of the test extracts 
were aseptically placed on the inoculated 
plates. The plates were incubated for 72 hours 
at 30 oC for filamentous fungi and 35 oC for 
24 hours for yeasts. After incubation, the 
diameter of inhibition zones for the all the 
extracts were measured and recorded as an 
indicator for activity.  
 
Serial dilution for the active extracts 
The extracts which had activity against 
some of the bacteria and fungi were then 
subjected to serial dilution to determine the 
Minimum Inhibitory Concentration (MIC) for 





the extracts. Microdilution using microtitre 
plates were used for serial dilutions; for every 
bioactive extract, each well in the microtitre 
plates was filled with 10 µl of DMSO. To the 
first whole 10 µl of the extract was added and 
thoroughly mixed with the 10 µl DMSO after 
which 10 µl of the mixture was added to the 
second whole. This process was repeated to 
all the holes until to the eleventh hole while 
the twelfth hole acted as the control with only 
DMSO in it. 
The dilutions from the wells were then 
subjected to bioactivity test using disc-
diffusion method to determine the zones of 
inhibition. The activity of the extracts were 
compared to that of the standard drug; 
chloramphenicol for bacteria and fluconazole 




Most of the extracts of Phytolacca 
dodecandra had terpenoids except for the 
methanol leaf and stem bark extract. Most of 
the extracts had phenolics except the stem 
bark hexane extract. Most of the extracts did 
not indicate the presence of flavonoids, 
anthraquinones and alkaloids except for the 
hexane leaf extract and dichloromethane root 
bark extract indicated the presence of 
alkaloids.  
The root barks of Phytolacca 
dodecandra showed highest concentration of 
terpenoids and phenolics as compared with 
the leaves and stems. In the leaves, terpenoids 
and phenolics had equal concentrations; the 
hexane extract had the highest concentration 
of terpenoid. Methanol extract indicated high 
concentration of phenolics and only hexane 
extract had alkaloids present. From the stem 
extract, phenolics were abundant among the 
compounds tested for. The ethyl acetate and 
hexane extracts had high concentrations of 
terpenoids as compared to the other extracts; 
dichloromethane extract had high 
concentration of phenolics as compared to the 
other extracts. In the roots, there were a lot of 
terpenoids as compared to the other 
compounds tested for; hexane and Ethyl 
acetate extracts having the highest 
concentration of terpenoids and hexane extract 
had the highest concentration of phenolics as 
compared to the other extracts (Table 1). 
Most of the leaf and stem extracts of 
Cucumis aculeatus indicated the presence of 
terpenoids and phenolics except for methanol 
leaf extract which did not indicate the 
presence of phenolics. However, most of the 
extracts did not indicate the presence of 
flavonoids, anthraquinones and alkaloids 
except for dichloromethane stem extract 
which indicated the presence of both 
anthraquinones and alkaloids; 
dichloromethane leaf extract indicated the 
presence of anthraquinones (Table 2). 
Anthraquinones were not present in any 
of the extracts of Erythrina excelsa. 
Terpenoids and phenolics were present in 
most of the extracts except for ethyl acetate 
which did not indicate the presence of 
phenolics. Flavonoids were only detected in 
dichloromethane extract of this plant and 
alkaloids were found present in 
dichloromethane and methanol extracts only 
(Table 3). 
 
Antibacterial and antifungal activities of 
test extracts of Phytolacca dodecandra  
The hexane extracts did not have any 
activity against any of the bacterial isolates 
used in the study. The dichloromethane 
extract had high activity against Pseudomonas 
aeruginosa. ATCC 27853, moderate activity 
on clinical isolate of Salmonella typhi but no 
activity against Staphylococcus aureus ATCC 
25923 and Escherichia coli ATCC 25922.  
Ethyl acetate extract had activity against P. 
aeruginosa ATCC 27853 but this was less 
than the activity of dichloromethane. The 
extracts had mild activity against clinical 
isolate of Salmonella typhi but no activity 





against Escherichia coli ATCC 25922 and 
Staphylococcus aureus ATCC 25923. The 
methanolic extract had no activity while 
aqueous extract had activity against P. 
aeruginosa ATCC 27853 only (Table 4). 
Dichloromethane, hexane, methanol and 
ethyl acetate extracts of leaves of Phytolacca 
dodecandra had no activity against the fungal 
isolates used in the study. Aqueous extract 
had moderate activity against Microsporum 
gypseum clinical isolate KMCC Mg 201 and 
Trychophyton mentagrophytes Clinical isolate 
KMCC TM 200 and mild activity against 
Candida albicans ATCC 90028. 
Dichloromethane, hexane, methanol and 
ethyl acetate extracts of Phytolacca 
dodecandra leaves had no activity against the 
fungal isolates used in the study. Aqueous 
extract had moderate activity against 
Microsporum gypseum Clinical isolate KMCC 
Mg 201 and Trychophyton mentagrophytes 
Clinical isolate KMCC TM 200 and mild 
activities against Candida albicans ATCC 
90028. The Phytolacca dodecandra leaf 
extracts had higher antibacterial activity as 
compared to antifungal activity (Tables 4 and 
5). The methanol extract of Phytolacca 
dodecandra stem bark was the most active 
against Salmonella typhi and P. aeruginosa 
ATCC 27853. P. aeruginosa ATCC 27853 
was the most susceptible bacterial isolate to 
dichloromethane, ethyl acetate, methanol and 
aqueous extracts (Table 5). 
For the fungal isolates it, was only the 
methanol extract of Phytolacca dodecandra 
stem bark which had antifungal activities 
except for Candida albicans ATCC 90028 in 
which there was no activity at all as indicated 
in Table 5. 
Dichloromethane and ethyl acetate 
extracts of the roots of Phytolacca 
dodecandra were active against P. aeruginosa 
ATCC 27853. The aqueous extract had very 
mild activity against Escherichia coli ATCC 
25922 while ethyl acetate also had mild 
activity against Salmonella typhi. Hexane and 
methanol extracts had no antibacterial activity 
against any of the bacterial isolates used in the 
study. 
Ethyl acetate of Phytolacca dodecandra 
roots had very mild antifungal activity against 
all the four fungal extracts used in the study, 
the methanol extract had antifungal activity all 
the four fungal isolates used in the study and 
this extract had higher activity on 
Microsporum gypseum Clinical isolate KMCC 
Mg 201 and Trychophyton mentagrophytes 
Clinical isolate KMCC TM 200 (Table 6). 
The aqueous extract had mild activity on 
Cryptococcus neoformans ATCC 66037 and a 
moderate antifungal activity on Candida 
albicans ATCC 90028 as shown in Table 6. 
The extracts from the roots of Phytolacca 
dodecandra had greater antifungal activity as 
compared to the antibacterial activity. 
   
Antibacterial and antifungal activity of test 
extracts of Cucumis aculeatus  
The hexane and methanol extracts of 
Cucumis aculeatus leaves had no antifungal 
activity; the aqueous extract exhibiting 
antifungal activity only on Trychophyton 
mentagrophytes Clinical isolate KMCC TM 
200 (Table 7). Dichloromethane extract had 
mild antifungal activity against Microsporum 
gypseum Clinical isolate KMCC Mg 201 and 
Trychophyton mentagrophytes Clinical isolate 
KMCC TM 200; ethyl acetate had mild 
activity on Microsporum gypseum Clinical 
isolate KMCC Mg 201 and Trychophyton 
mentagrophytes Clinical isolate KMCC TM 
200. The extracts from the leaves of Cucumis 
aculeatus had greater antibacterial activity as 
compared to the antifungal activity. 
From the stem extracts of Cucumis 
aculeatus, ethyl acetate extract had greater 
antibacterial activity against Pseudomonas 
aeruginosa ATCC 27853, very mild activity 
against Escherichia coli ATCC 25922 and 
Staphylococcus aureus ATCC 25923 and mild 





activity on Salmonella typhi Clinical isolate. 
Dichloromethane had activity against 
Pseudomonas aeruginosa ATCC 27853; 
hexane had activity against Escherichia coli 
ATCC 25922, Staphylococcus aureus ATCC 
25923 and Pseudomonas aeruginosa ATCC 
27853. Methanol had activity against 
Pseudomonas aeruginosa ATCC 27853 and the 
aqueous extract had activity against 
Salmonella typhi Clinical isolate (Table 8). 
The hexane and methanol stem extracts of 
Cucumis aculeatus had no antifungal activity 
against the fungal isolates used in this study. 
However, dichloromethane, methanol and 
aqueous extracts had antifungal against 
Microsporum gypseum Clinical isolate KMCC 
Mg 201 and Trychophyton mentagrophytes 
Clinical isolate KMCC TM 200 (Table 9). 
 
Antibacterial and antifungal activity of test 
extracts of Erythrina excelsa stem bark 
Dichloromethane, ethyl acetate and methanol 
extract had antibacterial activity against 
Staphylococcus aureus ATCC 25923; hexane, 
dichloromethane and aqueous had activity 
against Pseudomonas aeruginosa ATCC 27853 
(Table 10). Erythrina excelsa stem bark-
dichloromethane extract. 
 
Minimum Inhibitory Concentration (MIC)  
All the extracts in this investigation 
which showed bioactivity against any of the 
microorganisms used in the study were further 
subjected to serial dilution procedure. These 
extracts included Phytolacca dodecandra 
stem-methanol extract, leaves-
dichloromethane extract, roots-methanol 
extract, stem-dichloromethane extract, stem-
ethyl acetate extract, root-ethyl acetate extract, 
roots-dichloromethane extract. Cucumis 
aculeatus leaves-ethyl acetate extract, stem-
ethyl acetate extract, Phytolacca dodecandra 
leaves-water extract, Erythrina excelsa stem 
bark-dichlormethane extract and stem bark-
dichloromethane extract. 
Some of the extracts did not show any 
bioactivity against any of the bacteria and 
fungi tested thus their MIC could not be 
determined. These included Phytolacca 
dodecandra leaves ethyl acetate extract which 
showed no bioactivity against Salmonella 
typhi and Escherichia coli ATCC 25922. 
Phytolacca dodecandra leaves and roots water 
extracts showed no bioactivity against 
Candida albicans ATCC 90028. Phytolacca 
doecandra leaves dichloromethane and 
methanol extracts showed no activity against 
Salmonella typhi Clinical isolate. Phytolacca 
dodecandra roots ethyl acetate extract showed 
no activity against Cryptococcus neoformans 
ATCC 66037. Cucumis aculeatus leaves and 
stem ethyl acetate extracts and Cucumis 
aculeatus stem water extract showed no 
bioactivity against Salmonella typhi Clinical 
isolate. 
Phytolacca dodecandra stem methanol 
extract had higher antibacterial activity 
against P. aeruginosa ATCC 27853 with an 
MIC of 0.8625 mg/ml while for Cryptococcus 
neoformans ATCC 66037 the MIC was 5.5 
mg/ml. Phytolacca dodecandra roots 
dichloromethane extract had an MIC of 
0.3125 mg/ml with a zone of inhibition of 7 
mm for Pseudomonas aeruginosa ATCC 
27853. Cucumis aculeatus leaves ethyl acetate 
extract had an MIC of 0.9 mg/ml with a zone 
of inhibition of 8 mm for Pseudomonas 
aeruginosa ATCC 27853 but no activity for 
Salmonella typhi Clinical isolate. Cucumis 
aculeatus stem ethyl acetate extract had MIC 
of 1.45 mg/ml with a zone of inhibition of 7 
mm for Pseudomonas aeruginosa ATCC 
27853. Phytolacca dodecandra leaves water 
extract had MIC of 3.4 mg/ml with a zone of 
inhibition of 8 mm. Cucumis aculeatus tem  
hexane extract had MIC of 14.4 mg/ml with a 
zone of inhibition of 7 mm. Erythrina excelsa 
stem bark dichloromethane extract had MIC 
of 0.163 mg/ml and a zone of inhibition of 7 
mm.













Leaves Terpenoids ++++ + +++ - 
Phenolics + ++ ++ +++ 
Flavonoids - - - - 
Anthraquinones - - - - 
Alkaloids ++ - - - 
Stem bark Terpenoids + + +++ - 
Phenolics - +++ + ++ 
Flavonoids - - - - 
Anthraquinones - - - - 
Alkaloids - - - - 
Root bark Terpenoids +++ ++ +++ ++ 
Phenolics ++++ + ++ ++ 
Flavonoids - - - - 
Anthraquinones - - - - 
Alkaloids - - - - 
-   not determined;  +    low concentration;   ++    medium concentration;    +++     high concentration 





  Table 2: Phytochemical screening results for Cucumis aculeatus. 
 






Leaves Terpenoids +++ ++ ++ ++ 
Phenolics ++++ ++ ++ - 
Flavonoids - - - - 
Anthraquinones - + - - 
Alkaloids - - - - 
Stem Terpenoids +++ + +++ ++ 
Phenolics +++ ++ + ++ 
Flavonoids - - - - 
Anthraquinones - ++ - - 
Alkaloids - ++ - - 
-       not determined;  +      low concentration; ++       medium concentration; +++     high concentration; 









 Table 3: Phytochemical screening results of Erythrina excelsa (Root bark). 
 
Compounds Hexane Dichloromethane Ethyl acetate Methanol 
Terpenoids ++++ + + + 
Phenolics +++ + - +++ 
Flavonoids - ++ - - 
Anthraquinones - - - - 
Alkaloids - ++ - ++ 




Table 4: Antibacterial activity of test extracts of Phytolacca dodecandra.  
 
Test strains/Plant part 
Solvents/ Zones of inhibition and MIC (mg/ml) 
Hexane Dichloromethane Ethyl acetate Methanol Water 
Leave extract      
Salmonella typhi (Clinical 
isolate) 
- 10(N/A) 8(N/A) - - 
Escherichia coli ATCC 
25922 
- 6.5(N/A) 7(N/A) - 6.5(N/A) 
Staphylococcus aureus 
ATCC 25923 
- - - 6.5(N/A) - 
Pseudomonas aeruginosa 
ATCC 27853 
- 30(12) 14(N/A) 21(1.4) 17(1.4) 
Stem bark   
Salmonella typhi Clinical 
isolate 
- - 8 13 - 
Escherichia coli ATCC 
25922 
- - - - - 
Staphylococcus aureus 
ATCC 25923 
- - - - - 
Pseudomonas aeruginosa 
ATCC 27853 
- 22 (3.8) 22 (3.8) 50 (14) 11 (N/A) 
Root       
Salmonella typhi (Clinical 
isolate) 
- - 7 (N/A) - - 
Escherichia coli ATCC 
25922 
- - - - 6.5 (N/A) 
Staphylococcus aureus 
ATCC 25923 
- - - - - 
Pseudomonas aeruginosa 
ATCC 27853 
- 20 (2.5) 22 (3.5) - - 
-: No activity;  (N/A): MIC not determined due to lw activity. 





Table 5: Antifungal activity of extracts of Phytolacca dodecandra. 
 
Test strains / Plant part 
Solvents/Zones of inhibition and MIC (mg/ml) 
Hexane Dichloromethane Ethyl acetate Methanol Water 
Leaves      
Candida albicans ATCC 90028 - - - - 8(N/A) 
Microsporum gypseum (Clinical 
isolate KMCC Mg 201) - - 6.5(N/A) 7(N/A) 14(110) 
Cryptococcus neoformans ATCC 
66037 - - - - - 
Trychophyton mentagrophytes 
(Clinical isolate KMCC TM 200) - - 6.5(N/A) 7(N/A) 14(3.4) 
Stem bark      
Candida albicans ATCC 90028 - - - - - 
Microsporum gypseum Clinical 
isolate KMCC Mg 201 - - - 9(N/A) - 
Cryptococcus neoformans ATCC 
66037 - - - 8(14) - 
Trychophyton mentagrophytes 
Clinical isolate KMCC TM 200 - - - 9(N/A) - 
Root      
Candida albicans ATCC 90028 - - 8 9 10 (N/A) 
Microsporum gypseum Clinical 
isolate KMCC Mg 201 - - 7 (N/A) 16 - 
Cryptococcus neoformans ATCC 
66037 - - 7 (N/A) 10 (3.4) 8 (N/A) 
Trychophyton mentagrophytes 
Clinical isolate KMCC TM 200 - - 7 (N/A) 16 (3.4) - 
 
- : No activity; (N/A): MIC not determined due to lw activity. 





Table 6: Antibacterial activity of test extracts of Cucumis aculeatus leaves. 
 






Salmonella typhi Clinical 
isolate 
- - 8 (N/A) - - 
Escherichia coli ATCC 25922 - - 6.5 (N/A) - - 
Staphylococcus aureus ATCC 
25923 
- 8 (N/A) - 8 (N/A) - 
Pseudomonas aeruginosa 
ATCC 27853 
16 (N/A) - 38 (7.8) 9 (N/A) 12 (N/A) 
-  : No activity;  (N/A): MIC not determined. 
 
 
Table 7: Antifungal activity of test extracts of Cucumis aculeatus leaves. 
 
Test strains 







Candida albicans ATCC 
90028 
- - - - - 
Microsporum gypseum Clinical 
isolate KMCC Mg 201 
- 7 (N/A) 7 (N/A) - - 
Cryptococcus neoformans 
ATCC 66037 
- - - - - 
Trychophyton mentagrophytes 
Clinical isolate KMCC TM 
200 
- 7 (N/A) 10 (N/A) - 8 
- : No activity; (N/A) : MIC not determined. 
 
 
Table 8: Antibacterial activity of test extracts of Cucumis aculeatus tem. 
 
Test strains 






Salmonella typhi Clinical 
isolate 
- - 8 (N/A) - 10 (N/A) 
Escherichia coli ATCC 25922 10.5 (N/A) - 6.5 (N/A) - - 
Staphylococcus aureus ATCC 
25923 
10.5 (7.2) - 6.5 (N/A) - - 
Pseudomonas aeruginosa 
ATCC 27853 
14 (N/A) 18 (N/A) 50 (5.8) 7 (N/A) - 









Table 9: Antifungal activity of test extracts of Cucumis aculeatus tem. 
 
Test strains 






Candida albicans ATCC 
90028 
- - - - - 
Microsporum gypseum 
Clinical isolate KMCC 
Mg201 
- 7 (N/A) 10 (N/A) - 8 (N/A) 
Cryptococcus neoformans 
ATCC 66037 
- - - - - 
Trychophyton mentagrophytes 
Clinical isolate KMCC TM 
200 
- 7 (N/A) 10 (N/A) - 8 (N/A) 




Table 10: Antibacterial activity of test extracts of Erythrina excelsa stem bark. 
 
Test strains 






Salmonella typhi Clinical 
isolate 
- - - - - 
Escherichia coli ATCC 25922 - - - - - 
Staphylococcus aureus ATCC 
25923 
- 9 (0.16) 8 (N/A) 7 (N/A) - 
Pseudomonas aeruginosa 
ATCC 27853 
8 (N/A) 12 (N/A) - - 
18 
(N/A) 





From the extracts of root, stem barks 
and leaves of the P. dodecadra, C. aculeatus 
and E. excelta, phenolics and terpenoids were 
the most abundant among the compounds 
tested for. Flavonoids were identified mostly 
in E. excelta which is a confirmation of the 
presence of these comounds in Erythrina 
species (MI, 2010). Flavonoids are also 
widely used as antiplasmodial agents (Abiy, 
2003). Thus, confirming the rationalization for 
these traditional use of these herbal remedies 
in treating microbial and other conditions 
among the Nyanza community (Kokwaro, 
1993). The antibacterial activity against 
Staphylococcus aureus ATCC 25923 could be 
likely due to the presence of the flavonoids. 
From the results above, it was also clear 
that the plants Phytolacca dodecandra, 
Cucumis aculeatus and Erythrina excelsa 
could be the most reliable antimicrobial plants 
since their activity was consistent. Even after 
serial dilution, some extracts did not loose 
their activity. Their mild antibacterial and 
antifungal activity is a clear indication of their 
potential antimicrobial agents, especially if 





the compounds could be isolated and tested. 
The Phytolacca dodecandra stem MIC of 4 
µg/ml for P. aeruginosa ATCC 27853 with a 
minimum zone of inhibition of 22 mm and an 
MIC of 2 µg/ml for Escherichia coli ATCC 
25922 with a minimum zone of inhibition of 
26mm relates well with the tradition use of 
this plant. For example, the traditional use of  
Phytolacca dodecandra leaves  for treatment 
of  ringworms, roots and stem used for 
dysentery and other stomach disorders and the 
seeds are used as molluscidal, could be an 
effect of the presence of phenolics and 
terpenoids (Merkl, 2010; Kisangau, 2007). A 
few of the alkaloids were detected and these 
could be an indicator of synergism that could 
be causing these bioactivities.  
 
Conclusion 
Plants investigated have diverse 
compounds including phenolics, terpenoids, 
anthraquinones, alkaloids and flavonoids. 
These compounds are not evenly distributed 
in the plants. Phytolacca dodecandra extracts 
demonstrated antibacterial activity against 
Salmonella typhi Clinical isolate and 
Pseudomonas aeruginosa ATCC 27853 and 
antifungal activity against Microsporum 
gypseum Clinical isolate KMCC Mg 201 and 
Trychophyton mentagrophytes Clinical isolate 
KMCC TM 200 but very mild antifungal 
activity against Candida albicans ATCC 
90028 and Cryptococcus neoformans ATCC 
66037. Cucumis aculeatus extracts 
demonstrated antibacterial activity against 
Salmonella typhi Clinical isolate, Escherichia 
coli ATCC 25922, Staphylococcus aureus 
ATCC 25923 and Pseudomonas aeruginosa 
ATCC 27853. Cucumis aculeatus extracts 
also demonstrated antifungal activity against 
Microsporum gypseum Clinical isolate KMCC 
Mg201 and Trychophyton mentagrophytes 
Clinical isolate KMCC TM 200. Extracts from 
Erythrina excelsa demonstrated antibacterial 
activity against Staphylococcus aureus ATCC 
25923 and P. aeruginosa ATCC 27853. 
The above results justify the reason 
why these medicinal plants have been and are 
being used to treat the fungal and bacterial 
infections by the Luo community. These three 
plants under investigation have shown 
bioactivity against some fungi and bacteria. 
Further studies of active metabolites will be 
highly appreciated. However, there is also 
need to encourage the community to 
domesticate these medicinal plants. 
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